37 results for «1311»

Filter By

37 results

Mastering the future of PCI with drug-coated balloons

16 May 2024 – From EuroPCR 2024

Join this session dedicated to drug-coated balloons (DCB) to delve into the evolution of angioplasty with DCBs in the U.S. Learn about the established standard of care, balancing efficacy and safety in treating in-stent restenosis (ISR). Gain insights into the fundamental principles of angioplasty with DCB...

Mastering the future of PCI with drug-coated balloons

Complex coronary artery disease: can stents and DCB be complementary?

16 May 2023 – From EuroPCR 2023

DES and DCB, can these two technologies be complementary for the treatment of the same patient? What are the advantages and how to proceed? You will know everything by watching this presentation based on concrete cases.

Complex coronary artery

DCB PCI for de novo lesions: when and how?

15 May 2024 – From EuroPCR 2024

In this session, you will learn how to optimally perform DCB PCI, identify which lesions are best suited for this approach, and understand when it's necessary to switch from DCB to stent PCI. The session also features a debate on whether DCB-PCI should be the first...

DCB PCI for de novo lesions: when and how?

How do I confidently expand my DCB practice?

15 May 2024 – From EuroPCR 2024

This session offers insights on identifying appropriate lesions for DCB treatment, understanding the essential concepts for achieving optimal immediate results with DCB PCI, and exploring the long-term angiographic and clinical outcomes. The session emphasizes the importance of lesion preparation, notes that there are no contraindications for...

How do I confidently expand my DCB practice?

Current indications for DCB in de novo lesions

18 May 2023 – From EuroPCR 2023

If you are interested in learning more about drug-coated balloon angioplasty in de novo disease, don't miss this informative session, which incorporates real-life cases. The session begins with a comprehensive review of the top five papers published in the past year, focusing on this topic. Additionally,...

Current indications for DCB in de novo lesions

How do I confidently expand my drug-coated balloon practice?

21 May 2025 – From EuroPCR 2025

This EuroPCR 2025 session challenges the conventional approach to bifurcation PCI and dissection management. Learn why drug-coated balloons (DCB) may offer better long-term outcomes in cases where stents fall short, how DCBs can simplify bifurcation strategies, and why it’s time to rethink which dissections really need...

How do I confidently expand my drug-coated balloon practice?

Intracoronary imaging to guided DCB PCI

20 May 2026 – From EuroPCR 2026

This session highlights the role of intracoronary imaging techniques such as OCT and IVUS in guiding drug-coated balloon (DCB) PCI. It explores novel imaging-guided algorithms for complex bifurcations, prediction of drug-eluting balloon failure, management of calcified nodules, re-entry into true lumen during CTO, and tackling aneurysms...

Intracoronary imaging to guided DCB PCI

Complications following primary PCI

Consult this session to discover a selection of cases on complications following primary PCI, and learn more about the ping-pong technique, mechanical circulatory support in acute STEMI, an ultrahazardous complication associated with Impella and much more.

Complications following primary PCI

Nothing to fear - a guide to combine DCB and DES in hybrid PCI

19 May 2022 – From EuroPCR 2022

DCB in in-stent restenosis, DCB and DES, DCB in ACS, and a guide to use DCB in de novo lesions and bifurcations: this is the programme of this EuroPCR 2022 session devoted, not surprisingly, to drug-coated balloons.

Nothing to fear - a guide to combine DCB and DES in hybrid PCI

DCB in challenging scenarios - Part 1

21 May 2025 – From EuroPCR 2025

Discover the expanding role of drug-coated balloons (DCB) in challenging coronary interventions. This session covers their application in acute coronary syndrome complications, complex coronary artery disease revascularization, and in-stent restenosis at left main bifurcations, highlighting innovative combinations with drug-eluting stents for managing complex bifurcation and trifurcation...

DCB in challenging scenarios - Part 1

Back to the future - Lessons from the past that can guide contemporary practice

20 May 2026 – From EuroPCR 2026

Reflecting on historical perspectives in the management of atherosclerotic coronary vascular disease, this session imparts valuable lessons to guide contemporary PCI practice. It emphasizes best practices in vessel preparation, evaluates the significance of drug-eluting stents, and provides a pathologist’s insight into mechanisms of PCI failure to...

Back to the future - Lessons from the past that can guide contemporary practice

Which device for which patient: DES, BRS or DCB?

22 May 2025 – From EuroPCR 2025

This session provides comprehensive guidance on selecting the appropriate device—DES, BRS, or DCB—for individual patients and lesions. It examines patient and lesion characteristics, strengths and limitations of each device type, and regional considerations, illustrated by case presentations demonstrating practical device choice and resolution.

Which device for which patient: DES, BRS or DCB?

Is DCB a new valid option for coronary revascularisation?

22 May 2025 – From EuroPCR 2025

This session provides an in-depth evaluation of drug-coated balloons (DCB) as a valid option for coronary revascularisation. Topics include two-year follow-up comparisons between paclitaxel and sirolimus-coated balloons, clinical outcomes after bailout stenting post-DCB angioplasty, meta-analyses contrasting DCB and DES for large native coronary artery disease, and...

Is DCB a new valid option for coronary revascularisation?

The ARC consensus on DCB - evidence-based DCB technology

15 May 2024 – From EuroPCR 2024

In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.

Evidence-based on DCB technology that have dictated the ARC consensus on DCB

Is DCB the new gold standard for side branch treatment in bifurcation?

21 May 2026 – From EuroPCR 2026

This session explores the emerging role of drug-coated balloons (DCB) as a potential new standard for side branch treatment in bifurcation lesions. It focuses on selecting appropriate indications, optimal vessel preparation and delivery timing, and executing stepwise DCB strategies versus hybrid approaches to maximize clinical outcomes.

Is DCB the new gold standard for side branch treatment in bifurcation?

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

19 May 2022 – From EuroPCR 2022

Find out more about various studies & registries in drug-eluting balloons! A Sirolimus-coated balloon with micro-reservoir technology in coronary lesions, utilisation of DEB guided by post-PCI pressure gradient, DEB in combination with DES in the treatment of diffuse coronary artery disease,DEB for in-stent restenosis and plaque...

EuroPCR 2022 Hotlines / Late-Breaking Trials in Drug-eluting balloons: U-REDUCE STENT, HYPER, IMPROVED-CTO, and more!

Imaging-guided PCI for stent failure - LIVE case

16 May 2024 – From EuroPCR 2024

An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...

Imaging-guided PCI for stent failure - LIVE case
Didn’t find what you were looking for?